A new OTC option for infant and childhood constipation

Constipation affects approximately 8-12% of children in western populations,1 including 3% of 0–12 month-olds and 9.7% of 13–48 month-olds.2 Constipation may cause stress for children, carers, and the healthcare system including unnecessary hospital stays.3 Pharmacists have an important role in reducing the distress of childhood constipation including advising parents for what is “normal”, identification of